Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 17
- 13F valueReported value at the end of Q2 2026
- $39.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OGEN, Q2 2026
No superinvestor reported holding OGEN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Oragenics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 (view filing) | Dec 12, 2025 | 41 days | Telling FredDirector | SSale | −210 | $0.94 | −$197.4 | −18.1%948 after | Amended |
| Jun 18, 2025 (view filing) | Jun 17-18 | 1 day | Odyssey Health, Inc.10% Owner | SSaleCommon Stock - OGEN | −7.04K | $4.32 | −$30.4K | −100.0%0 after | 2 lots |
| Jun 16, 2025 (view filing) | Jun 13-16 | 3 days | Odyssey Health, Inc.10% Owner | SSaleCommon Stock - OGEN | −10.0K | $4.36 | −$43.6K | −58.7%7.04K after | 2 lots |
| Dec 9, 2024 (view filing)6:07 PM ET | Dec 6 | 3 days | Dunton Alan WDirector | SSale | −66 | $0.36 | −$23.76 | −0.3%25.6K after | |
| Dec 9, 2024 (view filing)4:23 PM ET | Dec 6 | 3 days | Telling FredDirector | SSale | −3.60K | $0.36 | −$1.29K | −9.4%34.7K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Telling FredDirector | SSale | −3.50K | $3.57 | −$12.5K | −8.4%38.3K after | |
| Jan 3, 2023 (view filing)4:20 PM ET | Dec 29, 2022 | 5 days | Koski Robert CDirector | SSale | −36.6K | $0.106 | −$3.88K | −17.2%176.2K after | |
| Jan 3, 2023 (view filing)4:20 PM ET | Dec 30, 2022 | 4 days | Koski Robert CDirector | SSale | −42.4K | $0.1055 | −$4.47K | −3.7%1.10M after | |
| Dec 16, 2022 (view filing)4:05 PM ET | Dec 14-15 | 2 days | Koski Robert CDirector | SSale | −165.5K | $0.1757 | −$29.1K | −12.6%1.14M after | 2 lots |
| Dec 15, 2022 (view filing)4:15 PM ET | Dec 14 | 1 day | Koski Robert CDirector | SSale | −4.50K | $0.175 | −$788.03 | −0.3%1.31M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Oragenics Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 23,685 | $13.8K | 0.00% | −41,387−63.6% | Reduced |
| 25 LLC | 23,160 | $13.4K | 0.00% | +23,160 | New |
| Jane Street Group, LLC | 12,771 | $7.41K | 0.00% | +12,771 | New |
| Tower Research Capital LLC (TRC) | 4,548 | $2.64K | 0.00% | 00.0% | Unchanged |
| St. Johns Investment Management Company, LLC | 1,924 | $1.12K | 0.00% | +1,724+862.0% | Added |
| BlackRock, Inc. | 703 | $408 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 642 | $373 | 0.00% | −4,563−87.7% | Reduced |
| Wells Fargo & Company | 34 | $20 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 34 | $20 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 23 | $13 | 0.00% | +12+109.1% | Added |